Soirée JLABS + Johnson & Johnson : le #bizdev dans les entreprises des sciences de la vie

Le 21 septembre à Usine IO, la structure JLABS, incubateurs de Johnson & Johnson, organise une soirée en partenariat avec Cap Digital, au cours de laquelle Nerida Scott, vice-présidente New Ventures & Transactions de Johnson & Johnson Innovation, abordera les fondamentaux du business development pour les entreprises des sciences de la vie.

Découvrez le descriptif (EN) de la soirée ci-dessous :

“Lessons in Herding Cats: Business Development Basics for Life Science Companies”

téléchargement (2)

How do you determine the direction that will add the most value to your company? How do you avoid the constant pursuit of « shiny objects? » How do you know when it’s the right time for a strategic partnership?

In this workshop, you’ll learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities.

Topics will include:

  • Strategic alliance process management
  • Concepts in valuation
  • Importance of IP and IP diligence
  • Communication and negotiation skills
  • Basic components of a contract.

This workshop is geared towards business development professionals and management teams of life science startups.


19:00 | Registration and Networking*

19:30 | Conference and Q&A

21:00 | Closing

*Light food & beverage provided


téléchargement (1)Nerida Scott, Ph.D.

Vice President, New Ventures & Transactions, Johnson & Johnson Innovation 

Nerida is responsible for a team of New Venture identifying, developing and executing transactions with a selection of the Innovation Centre’s diverse ecosystem of partners, including biotech companies, venture capital, non-profit organizations, governments, and academic institutions.

Nerida has over 15 years’ experience within the pharmaceutical sector. Before joining the Johnson & Johnson family, Nerida was the Business Development & Licensing Director and Executive team member at Vernalis PLC. In this position, she was responsible for leading transactions from their evaluations through to negotiation and closing. She has experience in licensing and collaboration transactions, as well as acquisitions and divestments. Previous experience includes business development at RiboTargets and Project Leader at The Boston Consulting Group in London where she provided strategic advice to the Pharma clients on M&A opportunities, R&D and manufacturing business functions. Nerida brings a broad and extensive background in operational and commercial activities in the R&D sector in both the US and the UK.


Usine IO
181 rue du Chevaleret, 75013 Paris


20 € | General Public
15 € | Student/Academic
30 € | At the door

Registration & information